Chronic lead exposure increases blood pressure and myocardial contractility in rats

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Fioresi, Mirian ^a   Simões, Maylla Ronacher ^a   Furieri, Lorena Barros ^a   Broseghini Filho, Gilson Brás ^a   Vescovi, Marcos Vinícius A ^a   Stefanon, Ivanita ^a   Vassallo, Dalton Valentim ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DRINKING WATER; LEAD; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; BONE LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; HEART RATE; HEMODYNAMIC PARAMETERS; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; MALE; NONHUMAN; RAT; REGULATORY MECHANISM; SARCOLEMMA; SARCOPLASMIC RETICULUM; SYSTOLIC BLOOD PRESSURE; WISTAR RAT; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; HEART CONTRACTION; METABOLISM; TOXICITY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; CALCIUM; LEAD; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM;

EID: 84901373039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096900     Document Type: Article

References (47)

1. World Health Organization (WHO) (2011) Cardiovascular Diseases. Available: http://www.who.int/cardiovasculardiseases/en/. Accessed 06 May 2011.
2. Agency for Toxic Substances and Disease Registry (ATSDR) (2007) Toxicological Profile for Lead. Atlanta GA: U.S. Department of Health and Human Services, Public Health Service.
3. Ministério da saúde, Brasil (2006) Atenção à saúde dos trabalhadores expostos ao chumbo metálico. Saúde do trabalhador. Protocolos de complexidade diferenciada. Normas e manuais técnicos. Brasília: Editora do Ministério da Saúde.
4. Den HE, Nawrot T, Staessen JA (2006) The relationship between blood pressure and blood lead in NHANES III. J Hum Hypertens 16: 563-568.
5. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ (2007) Lead exposure and cardiovascular disease - a systematic review. Environ Health Perspect 115: 472-482. (Pubitemid 46554449)
6. Pirkle JL, Schwartz J, Landis JR, Harlan WR (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemio 121: 246-258. (Pubitemid 15158536)
7. Vupputuri S, He J, Muntner P, Bazzano LA, Whelton PK, et al. (2003) Blood Lead Level Is Associated With Elevated Blood Pressure in Blacks. Hypertension 41: 463-468. (Pubitemid 36314617)
8. Vaziri ND, Ding Y, Ni Z, Gonick HC (1997) Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 52: 1042-1046. (Pubitemid 27435837)
9. Farmand F, Ehdaie A, Roberts CK, Sindhu RK (2005) Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylatecyclase. Environl Res 98: 33-39. (Pubitemid 40254942)
10. Sharifi AM, Darabi R, Akbarloo N, Larijani B, Khoshbaten A (2004) Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension. Toxicol Lett 153: 233-238. (Pubitemid 39296980)
11. Vaziri ND, Liang K, Ding Y (1992) Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56: 1492-1498.
12. Carmignani M, Boscolo P, Poma A, Volpe AR (1999) Kininergic system and arterial hypertension following chronic exposure to inorganic lead. Immunopharmacology 44: 105-110.
13. Fiorim J, Ribeiro Júnior RF, Silveira EA, Padilha AS, Vescovi MV, et al. (2011) Low-level lead exposure increases systolic arterial pressure and endothelium-derived vasodilator factors in rat aortas. PLoS One 10.1371/journal.pone.0017117.
14. Simões MR, Ribeiro Júnior RF, Vescovi MV, de Jesus HC, Padilha AS, et al. (2011) Acute lead exposure increases arterial pressure: role of the Renin-Angiotensin system. PloS One 10.1371/journal.pone.0018730.
15. Vassallo DV, Lebarch EC, Moreira CM, Wiggers GA, Stefanon I (2008) Lead reduces tension development and the myosin ATPase activity of the rat right ventricular myocardium. Braz J Med Res 41: 789-795.
16. Korecková-Sysalová J (1997) Determination of cadmium and lead levels in human blood of a general Czech population by GFAAS. Biol Trace Elem Res 53: 321-329.
17. Vassallo DV, Paes de Carvalho AP (1988) Influence of temperature on isometric contractions of rabbit atria during inotropic interventions. Acta Physiol Pharmacol Latinoam 29: 131-135.
18. Vassallo DV, Mill JG (1988) Mechanical behavior of rest contractions in cardiac muscle. Acta Physiol Pharmacol Latinoam 38: 87-97.
19. Leite CM, Vassallo DV, Mill JG (1995) Characteristics of tetanic contractions in caffeine-treated rat myocardium. Can J Physiol Pharmacol 73: 638-643.
20. Fioresi M, Furieri LB, Simões MR, Ribeiro RF Jr, Meira EF, et al. (2013) Acute exposure to lead increases myocardial contractility independent of hypertension development. Braz J Med Res 46: 178-185.
21. Oliveira EM, Santos RA, Krieger JE (2000) Standartization of a fluorimetric assay for the determination of tissue angiotensin-converting- activity in rats. Braz J Med Res 33: 755-764.
22. + ATPase activity are reduced early and late after myocardial infarction in rats. Braz J Med Biol Res 42: 902-911.
23. Leite CM, Vassallo DV, Mill JG (1988) The effect of verapamil on potentiated rest contractions in the rat ventricular myocardium Braz J Med Biol Res 21: 859-862.
24. +-ATPase α1 and α2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res 73: 92-100.
25. BRASIL, Ministério do Trabalho (1978) Norma Regulamentadora no 7. Programa de Controle Médico e Saúde Ocupacional. Diário Oficial [da] República Federativa do Brasil. Portaria GM no. 3.214.
26. Sun HW, Ma DJ, Chao CY, Liu S, Yuan ZB (2009) Lead distribution in blood and organs of mice exposed to lead by vein injection. Environ Technol 30: 1051-1057.
27. Grizzo LT, Cordellini S (2008) Lead Exposure Affects Nitric Oxide and Cyclooxygenase Pathways in Aorta of Weaned Rats. Toxicol Sci 103: 207-214. (Pubitemid 351524491)
28. 2+-independent contraction in rat aortic rings. Pharmacol Toxicol 89: 177-182.
29. Boscolo P, Carmignani M (1988) Neurohumoral Blood Pressure Regulation in Lead Exposure. Environ Health Perspect 78: 101-106.
30. Courtois E, Marques M, Barrientos A, Casado S, López-Farré A (2003) Lead-Induced Downregulation of Soluble GuanylateCyclase in Isolated Rat Aortic Segments Mediated by Reactive Oxygen Species and Cyclooxygenase-2. J Am Soc Nephrol 14: 1464-1470. (Pubitemid 36687047)
31. 2+) on the reactions of in vitro cultured rat aorta to 5-hydroxytryptamine. Toxicol Lett 159: 71-82.
32. Marques M, Millás I, Jiménez A, García-Colis E, Rodriguez-Feo JA, et al. (2001) Alteration of the Soluble GuanylateCyclase System in the Vascular Wall of Lead-Induced Hypertension in Rats. J Am Soc Nephrol 12: 2594-2600. (Pubitemid 33115405)
33. Silveira EA, Lizardo JH, Souza LP, Stefanon I, Vassallo DV (2010) Acute lead-induced vasoconstriction in the vascular beds of isolated perfused rat tails is endothelium-dependent. Braz J Med Biol Res 43: 492-499.
34. 2+) on the relaxation of in vitro cultured rat aorta to acetylcholine. Toxicol Lett 170: 104-110.
35. Khalil-Manesh F, Gonick HC, Weiler EW, Prins B, Weber MA, et al. (1993) Lead-induced hypertension: possible role of endothelial factors. Am J Hypertens 6: 723-729. (Pubitemid 23290740)
36. Heydari A, Norouzzadeh A, Khoshbaten A, Asgari A, Ghasemi A, et al. (2006) Effects of short-term and subchronic lead poisoning on nitricoxidemethabolites and vascular responsiveness in rat. Toxicol Lett 166: 88-94. (Pubitemid 44279308)
37. Roncal C, Mu W, Reungjui S, Kim KM, Henderson GN, et al. (2007) Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease. Am J Physiol Renal Physiol 293: 1391-1396.
38. Carmignani M, Volpe AR, Boscolo P, Quiao N, Di Gioacchino M, et al. (2000). Catecholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sciences 68: 401-415. (Pubitemid 32011893)
39. Okoshi MP, Tucci PJF, Cicogna AC (1994) O efeito Anrep. Arq Bras Cardiol 63: 501-505.
40. Stokke MK, Hougen K, Sjaastad I, Louch WE, Briston SJ, et al. (2010) Reduced SERCA2 abundance decreases the propensity for Ca wave development in ventricular myocytes. Cardiovasc Res 86: 63-71.
41. Quintanar-Escorza MA, González-Martínez MT, Navarro L, Maldonado M, Arévalo B, et al. (2007) Intracellular free calcium concentration and calcium transport in human erythrocytes of lead-exposed workers. Toxicol Appl Pharmaco 1: 1-8. (Pubitemid 46437256)
42. i concentration in human erythrocytes incubated with lead. Toxicol in Vitro 24: 1338-1346.
43. 2+ Channel Function. Mol Pharmacol 75: 774-781.
44. 2+ signaling in neonatal rat cardiac myocytes. Am J Physiol Cell Physiol 292: 2269-2275.
45. 2+-ATPase protein and activity. Am J Physiol Heart Circ Physiol 294: 2587-2595.
46. 2+. Biophys J 100: 1216-1225.
47. 2+)-ATPase during progression of left ventricular hypertrophy. Am J Physiol 272: 2416-2424.